The facility is designed primarily to produce two types of biological products from established cell lines: (1) clinical grade, intended for intravenous administration in humans and (2) non-clinical grade for use in research models. Manufacture and purification of products are performed in dedicated clinical and non-clinical areas of the facility in compliance with regulatory standards. Production of biological agents includes: monoclonal antibodies, fusion proteins, conjugates, plasmids, formulation of peptide vaccines and various other products derived from both eukaryotic and prokaryotic culture systems.
- Hutchinson Building, CD-150
- Mailing Address:
- P.O. Box 19025, MS CD-150 Seattle, WA 98109-1024
- (206) 667-5838
- Ron Manger, Ph.D. Staff Scientist and Director
A complete listing of Biologics Production employees is available from the directory.